PatentsGlobal
Telo Genomics Seeks U.S. Patent for Liquid Biopsy MRD Algorithm in Multiple Myeloma Management
Telo Genomics Corp. has filed a U.S. provisional patent application for a new TeloView® algorithm designed to predict relapse risk and isolate circulating cancer cells from liquid biopsy samples in multiple myeloma patients. This development aims to expand the company’s intellectual property portfolio and advance non-…
Thursday, July 9, 2026